Brief: GeNeuro And Karolinska Institutet/Academic Specialist Center To Launch New Clinical Study Of Temelimab

Geneuro SA

25/11/2019 06:41

Nov 25 (Reuters) - Geneuro SA  GNRO.PA :
    * GENEURO AND THE KAROLINSKA INSTITUTET/ACADEMIC SPECIALIST
CENTER
OF STOCKHOLM AGREE TO LAUNCH A NEW CLINICAL STUDY OF TEMELIMAB
IN MULTIPLE SCLEROSIS
    * COLLABORATION FOLLOWS DATA FROM ANGEL-MS EXTENSION TO
PHASE 2 MS
TRIAL
    * AIMS TO ADDRESS KEY UNMET NEED OF SLOWING OR STOPPING
DISEASE
PROGRESSION
    * THE STUDY AIMS TO START ENROLLING PATIENTS IN Q1 2020.

Source text for Eikon:  ID:nBw5Wr1N0a 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))